Breast Cancer Research

official impact factor 5.79

Download references

Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer

David W Miles

Breast Cancer Research 2009, 11:208 doi:10.1186/bcr2237

Include


Format